Sugi Predict

Sugi Predict / Compounds / SCHEMBL596057

SCHEMBL596057

SCHEMBL596057

O=S(=O)(O)c1ccc(P(c2ccc(S(=O)(=O)O)cc2)c2ccc(S(=O)(=O)O)cc2)cc1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 2/20 0.59
▸ ALDH1A1 P00352 6/20 0.56
▸ TSHR P16473 3/20 0.56
▸ NT5E P21589 1/20 0.56
▸ SMN1; SMN2 Q16637 2/20 0.55
▸ TDP1 Q9NUW8 4/20 0.50
▸ POLB P06746 1/20 0.46
▸ CYP2D6 P10635 1/20 0.46
▸ HSD17B10 Q99714 4/20 0.41
▸ KDM4E B2RXH2 3/20 0.41
▸ ESR1 P03372 2/20 0.39
▸ ESR2 Q92731 2/20 0.39
▸ NAPRT Q6XQN6 1/20 0.38
▸ HPGD P15428 1/20 0.38
▸ CA12 O43570 1/20 0.36
▸ CA1 P00915 1/20 0.36
▸ CA2 P00918 1/20 0.36
▸ CA7 P43166 1/20 0.36
▸ CA14 Q9ULX7 1/20 0.36
▸ CYP2C9 P11712 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL476685 1.00 LMNA (0.59) LMNAALDH1A1TSHRNT5ESMN1; SMN2
Sulfuric Acid SCHEMBL28088103 0.97 LMNA (0.56) LMNAALDH1A1TSHRNT5ESMN1; SMN2
SCHEMBL28966026 0.97 LMNA (0.56) LMNAALDH1A1TSHRNT5ESMN1; SMN2
SCHEMBL28966023 0.97 LMNA (0.56) LMNAALDH1A1TSHRNT5ESMN1; SMN2
SCHEMBL28966024 0.97 LMNA (0.56) LMNAALDH1A1TSHRNT5ESMN1; SMN2
SCHEMBL28229405 0.97 LMNA (0.56) LMNAALDH1A1TSHRNT5ESMN1; SMN2
SCHEMBL28966025 0.97 LMNA (0.56) LMNAALDH1A1TSHRNT5ESMN1; SMN2
SCHEMBL996850 0.91 TSHR (0.65) LMNAALDH1A1TSHRNT5ESMN1; SMN2
SCHEMBL718256 0.91 TSHR (0.65) LMNAALDH1A1TSHRNT5ESMN1; SMN2
SCHEMBL301148 0.89 TSHR (0.62) LMNAALDH1A1TSHRNT5ESMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 192 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6884751-B2 Production of hydrocyanation catalysts RHODIA FEBER & RESIN INTERMEDAITES (FR) 2005-04-26 — — US claimed
US-20020026066-A1 Production of hydrocyanation catalysts RHODIA FIBER AND RESIN INTERMEDIATES (FR) 2002-02-28 — — US claimed
EP-0715890-B1 Electrochemical preparation process of transition metal and phosphine containing catalysts RHONE POULENC FIBRES (FR) 1999-09-22 — — EP claimed
US-5908805-A COORDINATION COMPLEX OF TRANSITION METAL, PHOSPHINE BY REDUCTION, HYDROGENATION OF AQUEOUS SOLUTION R.P. FIBER & RESIN INTERMEDIATES (FR) 1999-06-01 — — US claimed
EP-0647619-B1 Process for the preparation of 2-methyl-3-butene nitrile RHONE POULENC FIBRES (FR) 1998-05-20 — — EP claimed
US-5679237-A ELECTROLYZING AQUEOUS SOLUTION CATHOLYTE CONTAINING TRANSITION METAL COMPOUND AND SULFONATED PHOSPHINE R. P. FIBER & RESIN INTERMEDIATES (FR) 1997-10-21 — — US claimed
EP-0650959-B1 Hydrocyanation process of unsatured nitriles into dinitriles RHONE POULENC CHIMIE (FR) 1997-09-03 — — EP claimed
WO-1996033969-A1 METHOD OF HYDROCYANATING UNSATURATED NITRILES INTO DINITRILES RHONE-POULENC CHIMIE (FR) 1996-10-31 — — WO claimed
EP-0722432-A1 METHOD FOR PREPARING OF MONO OR DI-2-SUBSTITUTED CYCLOPENTANONE RHONE-POULENC AGROCHIMIE (FR) 1996-07-24 — — EP claimed
EP-0715890-A1 Electrochemical preparation process of transition metal and phosphine containing catalysts RHONE-POULENC FIBER & RESIN INTERMEDIATES (FR) 1996-06-12 — — EP claimed
US-5488129-A CATALYST SYSTEM CONTAINING TRANSITION METAL COMPOUND, SULFONATED PHOSPHINE, LEWIS ACID RHONE-POULENC CHIMIE (FR) 1996-01-30 — — US claimed
US-5486643-A Isomerization of 2-methyl-3-butenenitrile RHONE-POULENC CHIMIE (FR) 1996-01-23 — — US claimed
EP-0650959-A1 Hydrocyanation process of unsatured nitriles into dinitriles RHONE-POULENC FIBER & RESIN INTERMEDIATES (FR) 1995-05-03 — — EP claimed
WO-1995009830-A1 METHOD FOR PREPARING OF MONO OR DI-2-SUBSTITUTED CYCLOPENTANONE RHONE POULENC AGROCHIMIE (FR) 1995-04-13 — — WO claimed
EP-0647619-A1 Process for the preparation of 2-methyl-3-butene nitrile RHONE-POULENC FIBER & RESIN INTERMEDIATES (FR) 1995-04-12 — — EP claimed
US-RE31812-E TO ALDEHYDES IN PRESENCE OF CATALYTIC SYSTEM CONTAINING RHODIUM AND SULFONATED ARYL PHOSPHINE COMPOUND RHONE-POULENC INDUSTRIES (FR) 1985-01-22 — — US claimed
US-4248802-A Catalytic hydroformylation of olefins RHONE-POULENC INDUSTRIES (FR) 1981-02-03 — — US claimed
US-12606512-B2 Process for the hydroformylation of olefins in homogeneous phase OXEA GMBH (DE) 2026-04-21 — — US disclosed
US-4142060-A DIENES, WATER RHONE-POULENC INDUSTRIES (FR) 1979-02-27 — — US disclosed
US-4087452-A Process of hydrocyanation of unsaturated organic compounds containing at least one ethylenic double bond RHONE-POULENC INDUSTRIES (FR) 1978-05-02 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020026066-A1 Production of hydrocyanation catalysts NOS2, NISCH, NOS1 LMNA 2743/4885ALDH1A1 3600/4885TSHR 4885/4885
US-12606512-B2 Process for the hydroformylation of olefins in homogeneous phase HMOX1, HAO2, AQP1 LMNA 3933/4885ALDH1A1 138/4885TSHR 3976/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.